NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., In...
Achaogen Competitors or Alternatives
Achaogen's top competitors include Spero Therapeutics, VIBATIV and Forge Therapeutics.
Achaogen VS Spero Therapeutics
Spero Therapeutics is Achaogen's top competitor. Spero Therapeutics is headquartered in Cambridge, Massachusetts, and was founded in 2013. Like Achaogen, Spero Therapeutics also operates in the Biotechnology field. Spero Therapeutics generates 2,284% the revenue of Achaogen.
Achaogen VS VIBATIV
VIBATIV is seen as one of Achaogen's top competitors. VIBATIV's headquarters is in San Francisco, California, and was founded in 1996. Like Achaogen, VIBATIV also works within the Biotechnology industry. VIBATIV generates 47% of Achaogen's revenue.
Achaogen VS Forge Therapeutics
Forge Therapeutics has been one of Achaogen's top competitors. Forge Therapeutics was founded in 2013, and its headquarters is in San Diego, California. Like Achaogen, Forge Therapeutics also works within the Biotechnology field. Forge Therapeutics has 25 more employees than Achaogen.
Looking for similar companies to Achaogen?
Similar Companies
Companies in South San Francisco with employees in 1-25 range
See 105 companies
Biotechnology companies in South San FranciscoSee 150 companies
Companies in South San Francisco with revenue in $100K-5.0M rangeSee 194 companies
Pharmaceuticals & Biotechnology companies in South San FranciscoSee 173 companies
Biotechnology companies in San Francisco Bay AreaSee 1,319 companies
Pharmaceuticals & Biotechnology companies in San Francisco Bay AreaSee 1,673 companies
Biotechnology companies in CaliforniaSee 3,097 companies
Biotechnology companies with employees in 1-25 rangeSee 3,305 companies
Pharmaceuticals & Biotechnology companies in CaliforniaSee 4,181 companies
Trending News for Achaogen and Achaogen's Competitors
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and meta...
The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular...
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) Friday announced that all resolutions at its Annual General Meeting were approved by shareholders, with over...
The Korean approval of Pfizer's Nurtec, an oral calcitonin gene-related peptide (CGRP) targeting drug for both acute and preventive treatment, is expec...
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 14, 2025 deadline to participate as a lead plaintiff in the securities fraud c...
Cipla receives USFDA approval for paclitaxel protein-bound particles for injectable suspension (albumin-bound), 100 mg/vial, single-dose vial...
The twice daily tablet represents a significant step forward for patients with advanced breast cancer....
Calcineurin Inhibitor Market is estimated to be valued at USD 12.37 Bn in 2025 and is expected to reach USD 25.36 Bn in 2032, exhibiting a compound ann...
NEW YORK , April 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK). Shareholders...
Frequently Asked Questions about Achaogen
Who are Achaogen's top competitors?
Achaogen's top 3 competitors are Spero Therapeutics, VIBATIV, Forge Therapeutics.Who is similar to Achaogen?
Spero Therapeutics is the most similar to Achaogen. VIBATIV and Forge Therapeutics are also similar to Achaogen.
Are Achaogen and Spero Therapeutics competitors?
Yes, Spero Therapeutics is one of Achaogen’s top competitors.